Cantor starts Affimed at OW; PT $12 - BioTuesdays

Cantor Starts Affimed At OW; PT $12 - BioTuesdays

1 week from now

Feb 23, 2022  · Cantor starts Affimed at OW; PT $12. February 23, 2022. Cantor Fitzgerald initiated coverage of Affimed N.V. ... Affimed, which is one of Cantor’s top picks for 2022, is a …

biotuesdays.com

Cantor Starts Cognition At OW; PT $12 - BioTuesdays

1 week from now

Sep 29, 2022  · Cantor Fitzgerald launched coverage of Cognition Therapeutics (NASDAQ:CGTX) with an “overweight” rating and 12-month price target of $12. The stock closed at $1.74 on …

biotuesdays.com

Cantor Starts PAVmed At OW; PT $8 | BioTuesdays : R/PAVM - Reddit

1 week from now

Posted by u/IvyMalise - 5 votes and no comments

reddit.com

BioTuesdays On LinkedIn: Cantor Starts Disc Medicine At OW; PT …

1 week from now

Cantor Fitzgerald launched coverage of Disc Medicine(NASDAQ:IRON) with an “overweight” rating and 12-month price target of $45. The stock closed at $32.24 on… BioTuesdays on …

linkedin.com

Cantor Fitzgerald Initiates Palvella Coverage With Overweight …

1 week from now

Palvella Therapeutics (NASDAQ: ANL) received a significant boost from Cantor Fitzgerald's recent initiation of coverage, with an "overweight" rating and a price target of $30 [1]. This …

ainvest.com

BioTuesdays On LinkedIn: Cantor Starts X4 Pharma At OW; PT $3

1 week from now

Cantor Fitzgerald launched coverage of X4 Pharmaceuticals (NASDAQ:XFOR) with an “overweight” rating and a 12-month price target of $3. The stock closed at 80 cents on Dec. 22 …

linkedin.com

Cantor Starts Pliant Therapeutics At OW; PT $12 - BioTuesdays

1 week from now

May 25, 2022  · Cantor Fitzgerald launched coverage of Pliant Therapeutics (NASDAQ:PLRX) with an “overweight” rating and 12-month price target of $12. The stock closed at $4.93 on May 24. …

biotuesdays.com

Transgene On LinkedIn: Cantor Starts Transgene At OW; PT €4

1 week from now

Cantor starts Transgene at OW; PT €4 - BioTuesdays

linkedin.com

BioTuesdays Na LinkedIn: Cantor Starts MindMed At OW; PT $3

1 week from now

Cantor Fitzgerald launched coverage of MindMed (NASDAQ:MNMD) with an “overweight” rating and price target of $3. The stock closed at 58 cents on Aug. 9. BioTuesdays na LinkedIn: …

linkedin.com

Cantor Starts Actinium Pharma At OW; PT $20 - BioTuesdays

1 week from now

Sep 8, 2022  · Cantor starts Actinium Pharma at OW; PT $20. September 8, 2022. Cantor Fitzgerald launched coverage of Actinium Pharmaceuticals (NYSE American:ATNM) with an …

biotuesdays.com

BioTuesdays On LinkedIn: Cantor Starts Acumen Pharma At OW; PT …

1 week from now

Cantor Fitzgerald initiated coverage of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) with an “overweight” rating and 12-month price target of $13. The stock closed at $5.45 on May 17 …

linkedin.com

Cantor Starts X4 Pharma At OW; PT $3 - BioTuesdays

1 week from now

Dec 22, 2022  · Cantor Fitzgerald launched coverage of X4 Pharmaceuticals (NASDAQ:XFOR) with an “overweight” rating and a 12-month price target of $3. The stock closed at 80 cents on …

biotuesdays.com

Cantor Starts Portage Biotech At OW; PT $35 - BioTuesdays

1 week from now

Aug 19, 2021  · Cantor Fitzgerald launched coverage of Portage Biotech (NASDAQ:PRTG) with an “overweight” rating and $35 price target. ... Cantor starts Portage Biotech at OW; PT $35. …

biotuesdays.com

Cantor Starts EFFECTOR Therapeutics At OW; PT $50 - BioTuesdays

1 week from now

Sep 13, 2021  · Cantor Fitzgerald launched coverage of eFFECTOR Therapeutics (NASDAQ:EFTR) with an “overweight” rating and price target of $50. The stock closed at …

biotuesdays.com

Cantor Starts 89bio At OW; PT $58 - BioTuesdays

1 week from now

Apr 21, 2021  · Cantor Fitzgerald launched coverage of 89bio (NASDAQ:ETNB) with an “overweight” rating and $58 price target. The stock closed at $25.81 on April 20. 89bio is …

biotuesdays.com